[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355832-105":59,"doc-detail-355832-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pkm2-lactylation-promotes-colorectal-cancer-vasculogenic-mimicry-and-bevacizumab-resistance-aars1fosl1-driven-fosl1-super-enhancer-formation","PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance - AARS1/FOSL1-Driven FOSL1 Super-Enhancer Formation","","Despite bevacizumab’s clinical value in advanced colorectal cancer, treatment resistance remains a key obstacle. This study identifies a lactate-mediated mechanism in which PKM2 lactylation at K206 promotes PKM2 nuclear translocation and binding to FOSL1. The PKM2–FOSL1 interaction drives FOSL1-dependent super-enhancer formation and target gene transcription, enabling vasculogenic mimicry. Inhibition of PKM2 lactylation disrupts vasculogenic mimicry and synergizes with bevacizumab in patient-derived preclinical models, improving therapeutic efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pkm2-lactylation-promotes-colorectal-cancer-vasculogenic-mimicry-and-bevacizumab-resistance-aars1fosl1-driven-fosl1-super-enhancer-formation/355832/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pkm2-lactylation-promotes-colorectal-cancer-vasculogenic-mimicry-and-bevacizumab-resistance-aars1fosl1-driven-fosl1-super-enhancer-formation/355832.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What mechanism links lactate metabolism to bevacizumab resistance in colorectal cancer cells?","Question",{"text":112,"@type":113},"The study shows that lactate-mediated PKM2 lactylation at K206 promotes nuclear translocation of PKM2 and its interaction with FOSL1, supporting vasculogenic mimicry linked to resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PKM2 lactylation contribute to vasculogenic mimicry (VM)?",{"text":117,"@type":113},"PKM2 binding facilitates FOSL1-dependent super-enhancer formation and target gene transcription, which drives colorectal cancer cell VM.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the therapeutic impact of inhibiting PKM2 lactylation together with bevacizumab?",{"text":121,"@type":113},"Genetic or pharmacologic inhibition of PKM2 lactylation disrupts VM and synergizes with bevacizumab in patient-derived preclinical models, significantly improving therapeutic efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355832,1790829977,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation  \nWeihao Li1,2, Jianhong Peng1,2, Jiahua He1,2, Leen Liao1,2, Da Kang1,2, Weili Zhang1,2, Weifeng Wang1,2, Ruowei Wang1,2, Song Wang1,2, Yuanbin Liao1,2, Long Yu1,2, Qingjian Ou1,2, Yujing Fang1,2,  \nXiaojun Wu1,2, Peirong Ding1,2, Zhizhong Pan1,2, Chi Zhou1,2, and Junzhong Lin1,2  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | 􀀶\u003Cbr>Despite the clinical utility of bevacizumab in advanced colorectal cancer, resistance remains a major challenge. In this study, we unveiled a lactate-mediated mechanism driving vasculogenic mimicry (VM) and bevacizumab resistance through PKM2 lactylation. PKM2 lactylation at K206 by AARS1 promoted PKM2 nuclear translocation and interaction with FOSL1. PKM2 binding facilitated FOSL1-dependent super-enhancer formation and target gene transcription, which contributed to colorectal cancer cell VM. Genetic or pharmacologic inhibition of PKM2 lactylation disrupted VM and synergized with bevacizumab in patientderived preclinical models, significantly improving therapeutic efficacy. Together, this study reveals lactylation as a metabolic switch linking cancer glycolytic reprogramming to transcriptional rewiring and proposes targeting PKM2 lactylation to enhance the antitumor activity of bevacizumab in colorectal cancer.\u003Cbr>Significance: PKM2 lactylation mediates vasculogenic mimicry by facilitating FOSL1-dependent super-enhancer formation and represents a potential target to improve the clinical efficacy of bevacizumab in colorectal cancer patients.\u003Cbr>\u003Cbr>Created in BioRender. Jiahua, H. (2026) [https://BioRender.com/j65w99k](https://BioRender.com/j65w99k). |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nColorectal cancer represents the third most common malignancy worldwide and the second leading cause of cancer-related deaths (1, 2) . Recurrence and distant metastasis are still the leading causes of treatment failure and death among patients with colorectal cancer (3, 4) . The application of doublet or triplet chemotherapy regimens with antiangiogenic therapy such as bevacizumab has increased response rates to 60% to 70%, increasing the survival of patients  \n1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. 2Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.  \nW. Li, J. Peng, and J. He contributed equally to this article.  \nCorresponding Authors: Zhizhong Pan, Department of Colorectal Surgery, Cancer Center, Sun Yat-sen University, 651 Dongfeng Road East, Guangzhou 510060, China. E-mail: [panzhzh@sysucc.org.cn](panzhzh@sysucc.org.cn); Chi Zhou,  \n[zhouchi@sysucc.org.cn](zhouchi@sysucc.org.cn); and Junzhong L","cbCaiprczIQ4GHmA","https://ap.wps.com/l/cbCaiprczIQ4GHmA","pdf",46358154,18,"English","# Introduction\n## Colorectal cancer burden and bevacizumab resistance\n## Anti-VEGF targeting limitations and vasculogenic mimicry (VM)\n## Hypoxia-associated metabolic reprogramming and VM formation","[{\"question\":\"What mechanism links lactate metabolism to bevacizumab resistance in colorectal cancer cells?\",\"answer\":\"The study shows that lactate-mediated PKM2 lactylation at K206 promotes nuclear translocation of PKM2 and its interaction with FOSL1, supporting vasculogenic mimicry linked to resistance.\"},{\"question\":\"How does PKM2 lactylation contribute to vasculogenic mimicry (VM)?\",\"answer\":\"PKM2 binding facilitates FOSL1-dependent super-enhancer formation and target gene transcription, which drives colorectal cancer cell VM.\"},{\"question\":\"What is the therapeutic impact of inhibiting PKM2 lactylation together with bevacizumab?\",\"answer\":\"Genetic or pharmacologic inhibition of PKM2 lactylation disrupts VM and synergizes with bevacizumab in patient-derived preclinical models, significantly improving therapeutic efficacy.\"}]","PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance - AARS1/FOSL1-Driven FOSL1 Super-Enhancer Formation | PDF",1790121251,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f787feee1407493bf53d239b0ea37071.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5933010c9e351508c69b0e65a5f56fb5.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a457530f6dcc2e9f6759d636879da011.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf350309b20fc5af85edefd411a0310c.webp",980,1311]